Piśmiennictwo:

1. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30 and May 1, 2002.

2. Ewaschuck JB, Madsen KL. Mechanisms of probiotic effects: a review. Functional Food Rev 2009;1:29-41.

3. Kligler B, Hanaway P, Cohrssen A. Probiotics in children. Pediatr Clin North Am 2007;54:949-67.

4. Szajewska H, Fordymacka A, Badrowski J, et al. Microbiological and genetic analysis of probiotic products licensed for medicinal purposes. Med Sci Monit 2004;10:BR346-350.

5. Hamilton-Miller JM, Shah S, Smith CT. “Probiotic” remedies are no what they seem. Br Med J 1996;312:55-6.

6. Gilliland SE, Speck ML. Enumeration and identity of lactobacilli in dietary products. Journal of Food Protection 1977;40:760-2.

7. Hoa NT, Baccigalupi L, Huxham A, et al. Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl Envir Microbiol 2000;66:5241-7.

8. Guarino A, Albano F, Ashkenazi S, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition/European Society for Paediatric Infectious Diseases Evidence-based Guidelines for the Management of Acute Gastroenteritis in children in Europe: Executive summary. J Pediatr Gastroenterol Nutr 2008;46:619-21.

9. Thomas DW, Greer FR; Committee on Nutrition; Section on Gastroenterology, Hepatology, and Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics 2010;126:1217-31.

10. Szajewska H, Ruszczyński M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials.

J Pediatr 2006;149(3):367-372.

11. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012;307:1959-69.

12. Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatrics 1999;135:564-8.

13. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999;104:e64.

14. Ruszczyński M, Radzikowski A, Szajewska H. Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-

-associated diarrhoea in children. Aliment Pharmacol Ther 2008;28:154-61.

15. Correa NB, Peret Filho LA, Penna FJ, et al. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol 2005;39:385-9.

16. Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2005;22:365-72.

17. Conway S, Hart A, Clark A, et al. Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice. Br J Gen Pract 2007;57:953-9.

18. Merenstein DJ, Foster J, D’Amico F. A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study. Arch Pediatr Adolesc Med 2009;163:750-4.

19. Hickson M, D’Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. Br Med J 2007;335:80-5.

20. Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther 2011;34:1079-87.

21. McFarland LV. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis 2007;5:97-105.

22. Szajewska H, Szabuńko M. Probiotyki w zapobieganiu biegunce podróżnych: metaanaliza badań z randomizacją. Zakażenia 2006;3:47-54.

23. Takahashi O, Noguchi Y, Omata F, et al. Probiotics in the prevention of traveler’s diarrhea: meta-analysis. J Clin Gastroenterol 2007;41:336-7.

24. Hao Q, Lu Z, Dong BR, et al. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2011 Sep 7;9:CD006895.

25. Hojsak I, Snovak N, Abdović S, et al. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr 2010;29:312-6.

26. Hatakka K, Savilahti E, Pönkä A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. Br Med J 2001;322:1327.

27. Merenstein D, Murphy M, Fokar A, et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr 2010;64:669-77.

28. Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized,double-blind, placebo-controlled trial. Pediatrics 2010;126:e526-33.

29. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 2011;33:1302-10.

30. Romano C, Ferrau’ V, Cavataio F, et al. Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health 2010 Jul 8. [Epub ahead of print].

31. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104 Suppl 1:S1-35.

32. Baker SS, Liptak GS, Colletti RB, et al. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1999;29:612-6.

33. Chmielewska A, Szajewska H. Systematic review of randomised controlled trias: probiotics for functional constipation. World J Gastroenterol 2010;16:69-75.

34. Banaszkiewicz A, Szajewska H. Ineffectivness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: double-blind, placebo-controlled randomized trial. J Pediatr 2005;146:364-9.

35. Tabbers MM, Chmielewska A, Roseboom MG, et al. Fermented milk containing Bifidobacterium lactis DN-173 010 in childhood constipation: a randomized, double-blind, controlled trial. Pediatrics 2011;127:e1392-9.

36. Coccorullo P, Strisciuglio C, Martinelli M, et al. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-

-controlled study. J Pediatr 2010;157:598-602.

37. Tong JL, Ran ZH, Shen J, et al. Meta-analysis: the effect of supplementation with probiotics on eradication rates and side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007;25:155-68.

38. Szajewska H, Horvath A, Piwowarczyk A. Meta-analysis of randomised controlled trials: Effect of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 2010;32:1069-79.

39. Mowat C, Cole A, Windsor A, et al. IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607.

40. Besselink MG, van Santvoort HC, Buskens E, et al. Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:651-9. Erratum: Lancet 2008;371:1246.

41. Sun S, Yang K, He X, et al. Probiotics in patients with severe acute pancreatitis:

a meta-analysis. Langenbecks Arch Surg 2009;394:171-7.

42. Deshpande G, Rao S, Patole S, et al. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010;125:921--30.

43. ESPGHAN Committee on Nutrition. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010;50:85-91.

44. van Goudoever JB, Koletzko B, Rigo J, et al, on behalf of the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010;50:694; author reply 694-5. Re: ESPGHAN commentary and education that probiotics substantially reduce all-cause mortality and necrotizing enterocolitis in preterm infants. Tarnow-Mordi W, Wilkinson D, Trivedi A, et al. Comment on: J Pediatr Gastroenterol Nutr 2010;50:85-91.

45. ESPGHAN Committee on Nutrition. Braegger Ch, Chmielewska A, Decsi T, et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2011;52:238-50.

46. Boyle RJ, Robins-Browne RM, Tang MLK. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 2006;83:1256-64.